From Bioblast
MitoGlobal first |
Mitochondria-Targeted Drug Development 2021 Virtual
Virtual , 2021 Apr 27-29. Mitochondria-Targeted Drug Development Summit |
ยป https://mitochondria-targets.com/
hansonwade (2021-04-27) MitoGlobal
Abstract: Mitochondria-Targeted Drug Development Summit, Digital, 2021.
General information
- The Digital Mitochondria-Targeted Drug Development Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring whatโs next to help you accelerate your pipeline into the clinic.
- Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial & Age-related Diseases.
- Download the brochure here
Program
- The program is available here
Registration
- Register here
- Early bird & Team Discounts Available
Organizer
- Hanson Wade
- Mail: [email protected]
- https://hansonwade.com/
Speaker
- Our 25+ expert speakers include:
- Douglas Wallace, Pediatric Mitochondrial Medicine & Metabolic Disease, Center for Mitochondrial & Epigenomic Medicine & University of Pennsylvania
- Magali Taiel, GenSight Biologics
- Mike Murphy, University of Cambridge
- Steven Engle, CohBar Inc
- John Geisler, Mitochon Pharmaceuticals
- Paul Thompson, MISSION Therapeutics
- Reenie McCarthy, Stealth BioTherapeutics
- Our 25+ expert speakers include:
- See the full list of speakers here
Listed under MitoGlobal Events.
Labels:
2021, MitoGlobal